Bevacizumab as first-line therapy for patients with brain metastases from renal carcinoma: a case series

Clin Genitourin Cancer. 2014 Jun;12(3):e107-10. doi: 10.1016/j.clgc.2013.12.005. Epub 2014 Jan 2.
No abstract available

Keywords: Antiangiogenic; Cerebral; Kidney; Target therapy; VEGF.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / secondary
  • Carcinoma, Renal Cell / diagnosis*
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / secondary
  • Female
  • Humans
  • Kidney Neoplasms / diagnosis*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / pathology
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / drug therapy

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab